ClinicalTrials.Veeva

Menu

The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children

P

Probi AB

Status and phase

Terminated
Phase 2

Conditions

Upper Respiratory Tract Infection

Treatments

Dietary Supplement: probiotic
Dietary Supplement: placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT01935986
U-12-032

Details and patient eligibility

About

The purpose of this study is to study the effect of a probiotic on protection against upper respiratory tract infections (URTI) in children.

Enrollment

131 patients

Sex

All

Ages

1 to 6 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy children

Exclusion criteria

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

131 participants in 2 patient groups, including a placebo group

probiotic
Experimental group
Description:
dietary supplement
Treatment:
Dietary Supplement: probiotic
placebo
Placebo Comparator group
Description:
dietary supplement without probiotic
Treatment:
Dietary Supplement: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems